A photo of Hee Kim.

Radiologist, Department of Radiology and Medical Imaging

Assistant Professor, UC Department of Radiology


Board Certified

My Biography & Research


I am a clinical provider and researcher at Cincinnati Children’s. My clinical specialties are pediatric musculoskeletal disorders and orthopedics. As a researcher, my interests include pediatric musculoskeletal disease and magnetic resonance (MR) techniques.

One particular disease I’m investigating is Duchenne muscular dystrophy (DMD), a degenerative genetic disorder that leads to muscle breakdown and weakness. My work aims to discover a cure for this debilitating and devastating disease.

My research has been funded by grants from the Radiological Society of North America (RSNA) and Cincinnati Children’s.

I obtained board certification from the American Board of Radiology in 2012.

Clinical Interests

Pediatric musculoskeletal disease

Research Interests

Advanced MR technique

Academic Affiliation

Assistant Professor, UC Department of Radiology

Clinical Divisions


Research Divisions


My Education

MD: Korea University College of Medicine, Guro Hospital, Seoul, Korea, 1999.

MA: Korea University College of Medicine, Seoul, Korea, 2004.

Residency: Resident in Radiology, Guro Hospital, Korea University College of Medicine, Seoul, Korea.

Certification: American Board of Radiology, July 2012.

My Publications

Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves' Disease and Hashimoto's Thyroiditis in Korean Patients. Yoon, JH; Shin, M; Kim, HN; Choi, W; Park, JY; Hong, AR; Kim, HK; Kang, H. Endocrinology and Metabolism. 2021; 36:599-606.

Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas. Park, JY; Choi, W; Hong, AR; Yoon, JH; Kim, HK; Jang, W; Jung, S; Kang, H. Pituitary. 2021.

Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice. Bang, YH; Hong, YS; Lee, JS; Lee, K; Han, HS; Kim, SY; Kim, J; Kim, HK; Kim, JW; Eun, CK; et al. Clinical Colorectal Cancer. 2021; 20:101-112.e6.

Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors. Yoon, JH; Hong, AR; Kim, HK; Kang, H. Endocrinology and Metabolism. 2021; 36:413-423.

Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer. Kim, HK; Kim, S; Jung, EK; Lee, K; Lee, JK; Kang, H; Joo, Y; Lim, SC; Yoon, TM. Oncology Reports. 2021; 45.

TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer. Han, HS; Jeong, S; Kim, H; Kim, H; Kim, AR; Kwon, M; Park, S; Woo, CG; Kim, HK; Lee, KH; et al. Cancer Letters. 2021; 499:137-147.

Adrenal insufficiency in hospitalized patients with multiple myeloma. Ahn, S; Kim, HK; Kang, H; Kim, M; Song, G; Jung, S; Ahn, J; Yang, D; Kim, H; Lee, J. Leukemia and Lymphoma. 2021; 62:501-503.

Association of Triglyceride-Glucose Index with Bone Mineral Density in Non-diabetic Koreans: KNHANES 2008-2011. Yoon, JH; Hong, AR; Choi, W; Park, JY; Kim, HK; Kang, H. Calcified Tissue International. 2021; 108:176-187.

Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype. Kim, HK; Lee, HS; Heo, MH; Kim, J; Ahn, JS; Im, Y; Lee, J; Park, YH. Clinical Breast Cancer. 2021.

Antimicrobial susceptibility of Staphylococcus species isolated from prosthetic joints with a focus on fluoroquinolone-resistance mechanisms. Darboe, KS; Oh, T; Choi, S; Kim, H; Kim, SE; Kim, UJ; Kang, S; Jang, H; Jung, S; Park, K. Diagnostic Microbiology and Infectious Disease. 2021; 99.